Australia Endoscopy Devices Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2026-2034

The Australia endoscopy devices market reached USD 1.06 Billion in 2025 and is projected to reach USD 1.69 Billion by 2034, growing at a CAGR of 5.21% during 2026-2034. The market is driven by the rising prevalence of gastrointestinal diseases, a growing shift toward minimally invasive procedures, expanding government-backed screening programs, and continued investment in advanced imaging technology. Endoscopes remain the leading product type, accounting for a considerable revenue share, while hospitals and clinics dominate the end-use landscape given their comprehensive diagnostic and therapeutic infrastructure.

Market Snapshot

The market expanded from an estimated USD 0.82 Billion in 2020 to USD 1.06 Billion in 2025, more than doubling in projected value over the following decade, anchored at USD 1.36 Billion in 2030 and forecast to reach USD 1.69 Billion by 2034. Sustained healthcare investment, an ageing population, and expanding screening participation underpin this steady upward trajectory across the historical and forecast periods alike.

To get more information on this market, Request Sample

Endoscopy visualization systems and ambulatory surgical centers grow fastest at approximately 6.1% and 6.4% CAGR respectively, as hospitals accelerate investment in upgraded imaging equipment and patients increasingly shift toward outpatient procedural settings. Endoscopes, the largest segment by revenue, grow broadly in line with the overall market at approximately 5.3% CAGR, sustained by steady replacement and expansion demand across hospitals and clinics nationwide.

The Australia endoscopy devices market reached USD 1.06 Billion in 2025, reflecting sustained demand for minimally invasive diagnostic and therapeutic tools across gastrointestinal, urological, gynecological, and orthopedic specialties. The endoscopy device is central to modern minimally invasive care, performing the visualization and intervention function that open surgical techniques previously required, and its adoption continues to expand as hospitals modernize diagnostic infrastructure. Government-backed screening programs, an ageing population, and rising chronic disease incidence continue to support procedural volumes nationwide, positioning the market for steady expansion through 2034.

Endoscopes dominate by type at 44.8% share, reflecting their central and repeated role across diagnostic and therapeutic procedures spanning multiple clinical specialties. Hospitals and clinics account for 73.6% of end use, supported by comprehensive infrastructure, specialist availability, and high patient throughput. Australia Capital Territory and New South Wales lead regionally at 31.8%, driven by dense hospital networks, higher screening participation, and greater concentration of specialist endoscopists relative to other Australian regions.

Key Market Insights

Key Analytical Observations Supporting the Above Data:

• Endoscopes at 44.8%: This segment leads as flexible and rigid endoscopes remain essential for both diagnosis and treatment across gastrointestinal, respiratory, and urological procedures. Continuous hospital investment in upgraded imaging capability and repeat procurement for procedural volume growth further strengthen this segment's leading position, and manufacturers are increasingly bundling AI-assisted software with new endoscope purchases.
• Hospitals and Clinics at 73.6%: High patient volumes, comprehensive infrastructure, and access to specialist endoscopists make hospitals and clinics the primary setting for both diagnostic and therapeutic endoscopic procedures nationwide, reinforcing their dominant share of overall end-use demand.
• ACT & New South Wales at 31.8%: The region leads through its dense concentration of major hospitals, higher screening participation, and greater healthcare spending relative to other Australian regions, supporting sustained device procurement and procedural throughput.

The Australia endoscopy devices market encompasses the design, distribution, and clinical use of instruments used for minimally invasive diagnosis and treatment across gastrointestinal, urological, gynecological, respiratory, and orthopedic conditions. The ecosystem integrates device manufacturers, imaging component suppliers, hospital procurement networks, distribution and servicing partners, and regulatory bodies such as the Therapeutic Goods Administration, alongside Medicare-funded screening programs that support broader adoption across metropolitan and regional healthcare settings. Macroeconomic factors, including rising healthcare expenditure, an ageing population, and growing preventive care awareness, continue to shape procurement priorities across public and private healthcare providers nationwide.

To evaluate market opportunities, Request Sample

Market Drivers

• Rising Prevalence of Gastrointestinal and Chronic Diseases: Colorectal cancer is projected to be Australia's fourth most diagnosed cancer in 2024, with over 15,500 new cases expected. This growing disease burden, alongside obesity, acid reflux, and other chronic digestive disorders, is fuelling sustained demand for diagnostic and therapeutic endoscopy across hospitals and clinics nationwide. The rising incidence of these conditions among Australia's ageing population further reinforces long-term procedural demand.
• Shift Toward Minimally Invasive Procedures: Patients increasingly prefer laparoscopic and endoscopic techniques over open surgery for reduced trauma, shorter hospitalization, and faster recovery. Healthcare providers are expanding flexible-scope and robotic-assisted capabilities to meet this rising preference across both diagnostic and surgical applications, supporting continued growth in device utilization rates.
• Government Healthcare Support and Screening Programs: Medicare and the National Bowel Cancer Screening Program subsidize endoscopic procedures and improve accessibility nationwide. Public hospital funding for modern endoscopy equipment, alongside expanding regional and tele-endoscopy services, is broadening procedural reach into underserved communities and reducing regional disparities in diagnostic access.
• Rising Medical Tourism: Australia's advanced healthcare system and highly qualified specialists are attracting a growing number of international patients seeking gastrointestinal and minimally invasive procedures, prompting hospitals to expand endoscopic capacity and invest in advanced imaging technologies.

Market Restraints

• High Cost of Advanced Endoscopy Systems: High-definition imaging, robotic-assisted platforms, and AI-enabled diagnostic systems carry significant upfront and maintenance costs, which can slow adoption among smaller regional clinics and ambulatory centers operating with constrained capital budgets.
• Shortage of Trained Endoscopists: A limited pool of specialist-trained clinicians, particularly across regional and rural Australia, restricts procedural throughput and can extend patient waiting times for both screening and therapeutic endoscopy services.
• Stringent Regulatory and Reimbursement Requirements: Therapeutic Goods Administration approval pathways and evolving Medicare reimbursement criteria can lengthen product launch timelines, adding compliance costs for manufacturers seeking to introduce new endoscopic devices into the Australian market.

Market Opportunities

• AI-Powered Diagnostic Platform Expansion: The integration of cloud-based AI detection software into existing endoscopy systems creates significant upgrade revenue for manufacturers, as hospitals seek to improve polyp detection rates and diagnostic consistency without replacing entire imaging platforms. Wider adoption across metropolitan and regional facilities is expected to open a durable software and licensing revenue stream alongside traditional device sales.
• Tele-Endoscopy and Regional Access Expansion: Government investment in regional and remote healthcare connectivity is enabling tele-endoscopy consultations and mobile screening services, extending specialist diagnostic capability beyond major metropolitan hospitals. This creates an emerging opportunity for manufacturers and distributors offering portable, connected endoscopic imaging solutions suited to regional deployment.

Market Challenges

• Competition from Established Global Suppliers Limiting Local Share: Global medical technology leaders with deep product portfolios and established hospital relationships create high barriers to entry for smaller domestic distributors and emerging device manufacturers seeking to expand share within the Australian market.
• Rising Procedural Complexity Requiring Continuous Specialist Training: As robotic-assisted and AI-integrated endoscopic systems become more sophisticated, hospitals face ongoing costs and scheduling constraints associated with specialist training and credentialing, which can slow the pace of new technology adoption across smaller facilities.

1. AI-Powered Diagnostic Support Enhancing Colonoscopy and GI Screening Accuracy

AI-powered diagnostic support is transforming colonoscopy and broader gastrointestinal screening by helping clinicians detect polyps and lesions with greater consistency in real time. Cloud-based computer-aided detection platforms are increasingly integrated into existing endoscopy systems, improving diagnostic accuracy without requiring full equipment replacement. As Australian hospitals prioritize early cancer detection under national screening programs, adoption of AI-assisted endoscopy platforms is expected to accelerate across major metropolitan and regional healthcare networks.

2. Expansion of Single-Use Endoscope Adoption Reducing Infection-Control Burden

The adoption of single-use endoscopes is expanding as hospitals seek to reduce the risk of cross-contamination and reprocessing costs associated with reusable scopes. These devices eliminate the need for sterilization between procedures, making them particularly attractive for urology and bronchoscopy applications with high infection-control sensitivity. Boston Scientific's continued rollout of single-use flexible endoscopes reflects this broader industry shift toward disposable diagnostic tools. As Australian healthcare providers place greater emphasis on infection prevention and streamlined procedural workflows, single-use endoscope adoption is expected to expand across both hospital and ambulatory surgical center settings.

3. Tele-Endoscopy and Regional Screening Access Expansion

Tele-endoscopy is emerging as a key enabler of diagnostic access in regional and remote Australia, where specialist availability remains limited. Cloud-connected imaging systems allow remote specialists to review procedures in real time, supporting diagnostic consistency without requiring patient travel to major metropolitan centers. Government investment in regional healthcare connectivity and mobile screening services is reinforcing this trend, particularly for bowel cancer screening initiatives. As telehealth infrastructure matures nationally, tele-endoscopy is expected to play an increasingly important role in extending specialist diagnostic capability to underserved communities.

4. Robotic-Assisted Endoscopy Adoption for Complex Therapeutic Procedures

Robotic-assisted endoscopy platforms are gradually entering Australian hospitals for complex therapeutic interventions, offering improved precision, stability, and control during extended procedures. These systems reduce operator fatigue and support more consistent outcomes in advanced interventions such as endoscopic submucosal dissection. While adoption remains concentrated in leading metropolitan hospitals, growing clinical evidence supporting robotic-assisted outcomes is expected to drive wider uptake across major Australian healthcare networks through the forecast period.

The Australia endoscopy devices value chain integrates component and raw material sourcing, device manufacturing and assembly, quality testing and regulatory approval, distribution and hospital procurement, clinical use, and after-sales servicing and sterilization support. Distribution and servicing partners play an increasingly important role in maintaining equipment uptime and extending device lifecycle across metropolitan and regional healthcare facilities. As device sophistication increases, the servicing and sterilization stage is becoming an increasingly commercially significant part of the value chain, given the specialized infrastructure required to maintain infection-control compliance.

High-Definition and 4K Imaging Systems

High-definition and 4K imaging technologies offer superior resolution, contrast, and detail during diagnostic and therapeutic procedures, improving clinicians' ability to identify subtle lesions and abnormalities. Their growing integration into flexible and rigid endoscopy platforms is strengthening procedural accuracy across Australian hospitals and specialist clinics.

AI-Assisted Diagnostic Software

AI-assisted diagnostic software analyzes real-time endoscopic video to flag suspected polyps and lesions, supporting faster and more consistent clinical decision-making. Adoption is expanding across Australian gastroenterology departments as hospitals prioritize diagnostic accuracy and standardized screening outcomes.

Single-Use Endoscope Technology

Single-use endoscope technology eliminates reprocessing requirements and reduces cross-contamination risk, making it increasingly attractive for urology, bronchoscopy, and other high-throughput applications. Continued cost reduction in single-use manufacturing is expected to broaden adoption across both hospital and ambulatory surgical center settings.

The report covers the following segments:

By Type

Endoscopes lead the market at 44.8% in 2025, given their essential and repeated use across gastrointestinal, respiratory, and urological procedures. Operative devices follow at 26.5%, supporting therapeutic interventions performed alongside diagnostic endoscopy, particularly in surgical and interventional settings.

To access detailed market analysis, Request Sample

Endoscopy visualization systems hold 17.4% share, reflecting hospital investment in high-definition imaging and video processing equipment, while visualization components account for 11.3%, comprising cameras, processors, and monitors that support core endoscopic equipment across procedure types.

By End Use

Hospitals and clinics lead end use at 73.6% in 2025, given their comprehensive infrastructure, specialist availability, and high patient throughput for both diagnostic and therapeutic procedures across the country.

Ambulatory surgical centers hold 18.9% share, offering cost-efficient outpatient procedures with shorter recovery times, while other settings, including specialty clinics and diagnostic imaging centers, account for the remaining 7.5% of end-use demand.

Regional Market Insights

ACT & New South Wales leads through its concentration of major hospitals and higher screening participation.

Victoria & Tasmania and Queensland follow, supported by expanding public healthcare investment, while Western Australia and Northern Territory & South Australia represent smaller but steadily growing markets as regional healthcare access continues to improve. Continued investment in tele-endoscopy and mobile screening infrastructure is expected to narrow the gap between leading and emerging regions over the forecast period, gradually broadening the geographic distribution of procedural volumes nationwide.

The Australia endoscopy devices market competitive landscape features a mix of global medical technology leaders and domestic distribution specialists. Companies compete on imaging technology, product breadth, clinical training support, and after-sales service networks, with recent activity including facility investments and local acquisitions strengthening nationwide support capability across metropolitan and regional healthcare markets. Pricing pressure from group hospital procurement contracts is also prompting suppliers to differentiate through service quality and software-enabled diagnostic value rather than hardware price alone.

Key players include Olympus Corporation, Medtronic, FUJIFILM Holdings Corporation, Stryker, Karl Storz SE & Co. KG, and others.

Olympus Corporation

Olympus Corporation is a Japan-based manufacturer with a leading presence in Australia's endoscopy devices market through its flexible endoscope and video imaging systems, supported by a nationwide sterilization and servicing network. The company's long-standing relationships with major public and private hospital networks reinforce its position as the market's most established supplier.

• Key Products: Flexible GI endoscopes, EVIS video imaging systems.
• Recent Developments: In September 2024, Olympus Australia launched Sapphire, Melbourne's first flexible endoscope sterilisation facility, under its On-Demand program, supplying sterilised, ready-to-use scopes to hospitals nationwide and streamlining infection control workflows.
• Strategic Focus: Expanding sterilisation and on-demand equipment access to strengthen infection control and hospital service reliability across metropolitan and regional Australia.

Medtronic

Medtronic is a global medical device company advancing AI-assisted endoscopic diagnostics, supporting improved detection accuracy in gastrointestinal screening programs relevant to the Australian healthcare system. Its continued investment in software-driven diagnostic tools reflects a broader industry shift toward intelligent, data-enabled endoscopy platforms.

• Key Products: GI Genius AI-assisted detection module, endoscopic instruments.
• Strategic Focus: Integrating artificial intelligence into endoscopic screening workflows to support earlier disease detection and improved clinical outcomes nationwide.

The Australia endoscopy devices market is moderately concentrated, with global leaders collectively holding a substantial share of hospital procurement. Domestic distributors support last-mile servicing and equipment maintenance, while regional players continue to gain share through localized technical support and after-sales care across less densely served areas. Market concentration is expected to gradually ease over the forecast period as domestic servicing specialists expand their footprint and as AI-software providers introduce new competitive dynamics beyond traditional hardware manufacturing.

Highest Growth Segments

Endoscopes, AI-assisted diagnostic modules, and single-use endoscope categories represent the highest-growth product segments through 2034, supported by rising procedural volumes and infection-control priorities across Australian healthcare facilities. Ambulatory surgical centers are also expected to outpace overall market growth as outpatient procedure adoption accelerates.

Emerging Investment Opportunities

Ambulatory surgical centers represent a rising investment opportunity as outpatient procedure volumes increase, supported by cost efficiency and shorter recovery times relative to inpatient settings. Tele-endoscopy infrastructure targeting regional and remote communities also presents a structurally growing opportunity as government programs continue expanding screening access nationwide, creating demand for portable and connected diagnostic equipment.

Investment Themes

• AI-Assisted Diagnostic Platform Integration: Investment in AI-powered detection software offers manufacturers a differentiated value proposition as hospitals prioritize diagnostic accuracy and procedural efficiency improvements, creating recurring software revenue alongside traditional hardware sales.
• Regional Service Network Expansion: Expanding distribution and servicing infrastructure into regional Australia strengthens equipment uptime and captures growing demand from underserved healthcare markets outside major metropolitan centers.
• Single-Use Device Manufacturing Scale-Up: Investment in single-use endoscope production capacity allows manufacturers to capture rising infection-control-driven demand while benefiting from improving unit economics as production volumes scale.

The Australia endoscopy devices market is projected to grow from USD 1.06 Billion in 2025 to USD 1.69 Billion by 2034, delivering a 5.21% CAGR over the forecast period. The market's anchor value of USD 1.36 Billion in 2030 reflects continued healthcare investment as AI-assisted imaging, single-use devices, and expanded screening access sustain steady procedural volume growth nationwide. By the end of the forecast period, AI-assisted diagnostic modules and single-use endoscope formats are expected to have moved from emerging technologies to standard specification across most major Australian hospital networks.

Two structural forces support this trajectory with confidence. Australia's ageing population and rising chronic disease burden create a self-reinforcing cycle of screening demand and device procurement, while continued government investment in regional and tele-health infrastructure extends procedural access into previously underserved communities, broadening the addressable base for endoscopy device manufacturers and distributors alike. Together, these forces are expected to sustain steady, broad-based market growth through 2034 rather than growth concentrated in a small number of metropolitan centers.

Primary Research

Primary research comprised structured interviews with hospital procurement leads, gastroenterologists, endoscopy nurses, and device distributors across Australia to validate market size, segmentation, and competitive positioning. These interviews also informed qualitative assessments of technology adoption timelines and regional access constraints.

Secondary Research

Secondary sources included company annual reports, Therapeutic Goods Administration filings, Australian Institute of Health and Welfare data, and industry association publications covering endoscopy procedure volumes and screening participation rates. Additional cross-referencing against public hospital funding disclosures supported forecast validation.

Forecasting Models

Market forecasts were developed using a bottom-up approach combining historical procedure volumes, hospital capital expenditure trends, and segment-level growth assumptions by type, end use, and region, cross-validated against top-down healthcare expenditure benchmarks. Sensitivity checks were applied to account for potential variation in screening program funding and technology adoption rates across the forecast period.

Australia Endoscopy Devices Market Report Coverage:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia endoscopy devices market from 2020-2034.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia endoscopy devices market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia endoscopy devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.